Dr. Phelan offers advanced facial rejuvenation procedures at Boston Plastic Surgery including facelift, neck lift, eyelid ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

As the New Year begins, the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) is urging the public to avoid ...

According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...

The US FDAd re-issued a decision first made in October that a shortage of the diabetes/weight-loss medication tirzepatide is ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity ...

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Already, Novo showed its weight loss drug Wegovy can prevent an array of heart issues ... Lilly’s trial has enrolled more ...

Discover why health professionals are raising red flags about fat burners, their hidden dangers, and what science says about safer alternatives for we ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...